Company Filing History:
Years Active: 2007
Title: Anlong Xu: Innovator in Neurotoxin Research
Introduction
Anlong Xu is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of neurotoxin research, particularly through his innovative work involving genes derived from sea snake venom. His research has implications for pain management and therapeutic applications.
Latest Patents
Anlong Xu holds 1 patent related to his groundbreaking work. In this invention, three genes encoding short chain neurotoxins were obtained by constructing a cDNA library from the venom gland of a sea snake and performing DNA sequencing. The genes, named sn12, sn36, and sn160, were modified and amplified using the PCR method and subsequently cloned into the expression vector PETTRX. These neurotoxin genes were expressed in soluble fusion proteins in the BL21-DE3 strain, which served as the expression host when induced with IPTG. Studies on the analgesic effects of the three recombinant short chain neurotoxins demonstrated that all three proteins, SN12, SN36, and SN160, significantly increased the pain threshold value in mice.
Career Highlights
Anlong Xu is affiliated with Zhongshan University, where he continues to advance his research in neurotoxin applications. His work has garnered attention for its potential to contribute to pain relief therapies, showcasing his commitment to scientific innovation.
Collaborations
Anlong Xu collaborates with notable colleagues, including Xiaofen Zhong and Lisheng Peng. Their combined expertise enhances the research output and fosters a collaborative environment for scientific discovery.
Conclusion
Anlong Xu's contributions to neurotoxin research exemplify the impact of innovative thinking in the field of biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.